Increasing treatment options for cannabis dependence: A review of potential pharmacotherapies

This publication has 89 references indexed in Scilit:

• Causal association between cannabis and psychosis: examination of the evidence
  The British Journal of Psychiatry, 2004
• Prostaglandin E2 attenuates SR141716A-precipitated withdrawal in tetrahydrocannabinol-dependent mice
  Brain Research, 2003
• Dose-related neurocognitive effects of marijuana use
  Neurology, 2002
• Marijuana abstinence effects in marijuana smokers maintained in their home environment.
  Archives of General Psychiatry, 2001
• Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system
  Neuroscience, 2001
• Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system
  European Journal of Pharmacology, 2001
• Effects of the cannabinoid CB1 receptor antagonist, SR141716A, after Δ9-tetrahydrocannabinol withdrawal
  European Journal of Pharmacology, 2000
• Marijuana withdrawal among adults seeking treatment for marijuana dependence
  Addiction, 1999
• Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: Basic findings from the National Comorbidity Survey.
  Experimental and Clinical Psychopharmacology, 1994
• Clonidine vs chlordiazepoxide in the management of acute alcohol withdrawal syndrome
  Archives of internal medicine (1960), 1987